|
C6ORF134 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.62560015132863E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.77070000065783E-09 |
| Normal-vs-Stage2 |
2.040000E-02 |
| Normal-vs-Stage3 |
6.771600E-02 |
| Normal-vs-Stage4 |
1.024000E-01 |
| Stage1-vs-Stage2 |
8.530400E-01 |
| Stage1-vs-Stage3 |
5.874100E-02 |
| Stage1-vs-Stage4 |
4.449000E-01 |
| Stage2-vs-Stage3 |
2.176800E-01 |
| Stage2-vs-Stage4 |
5.572600E-01 |
| Stage3-vs-Stage4 |
6.826200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.88170043383218E-10 |
| Normal-vs-AfricanAmerican |
7.64680000000517E-05 |
| Normal-vs-Asian |
2.062600E-01 |
| Caucasian-vs-AfricanAmerican |
2.767400E-01 |
| Caucasian-vs-Asian |
2.750000E-01 |
| AfricanAmerican-vs-Asian |
4.336600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.59640003835915E-09 |
| Normal-vs-Female |
4.94220000035739E-07 |
| Male-vs-Female |
4.378400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.831500E-04 |
| Normal-vs-Extreme_Weight |
3.81449999997674E-06 |
| Normal-vs-Obese |
1.62193999999616E-05 |
| Normal-vs-Extreme_Obese |
4.355800E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.834800E-01 |
| Normal_Weight-vs-Obese |
3.073600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.954200E-01 |
| Extreme_Weight-vs-Obese |
3.217800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.291600E-01 |
| Obese-vs-Extreme_Obese |
5.901800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.024400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.47819995027976E-10 |
| Normal-vs-Age(61-80Yrs) |
1.48829999990774E-07 |
| Normal-vs-Age(81-100Yrs) |
6.611600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.172200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.707600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.296040E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.579600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.819700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.824700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.56221735337203E-14 |
| Normal-VS-Type2 PRCC |
2.315600E-01 |
| Normal-VS-KIRP CIMP |
4.574200E-01 |
| Normal-VS-Unclassified PRCC |
1.419980E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.19424519957101E-13 |
| Type1 PRCC-VS-KIRP CIMP |
1.283860E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.332630E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.262000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.940000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.151000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.202400E-03 |
| Normal-vs-N1 |
1.184370E-02 |
| Normal-vs-N2 |
8.104600E-01 |
| N0-vs-N1 |
7.119800E-01 |
| N0-vs-N2 |
1.935220E-01 |
| N1-vs-N2 |
1.870800E-01 |
|
|
